|
ZNF432 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.199420E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.623170E-03 |
| Normal-vs-Stage2 |
2.778400E-02 |
| Normal-vs-Stage3 |
8.843500E-03 |
| Normal-vs-Stage4 |
6.657900E-02 |
| Stage1-vs-Stage2 |
7.496800E-01 |
| Stage1-vs-Stage3 |
6.852200E-01 |
| Stage1-vs-Stage4 |
4.829000E-01 |
| Stage2-vs-Stage3 |
9.758600E-01 |
| Stage2-vs-Stage4 |
6.521600E-01 |
| Stage3-vs-Stage4 |
6.414200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.206600E-04 |
| Normal-vs-AfricanAmerican |
3.282000E-02 |
| Normal-vs-Asian |
9.595000E-01 |
| Caucasian-vs-AfricanAmerican |
7.361600E-01 |
| Caucasian-vs-Asian |
3.285600E-01 |
| AfricanAmerican-vs-Asian |
4.200800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.018950E-04 |
| Normal-vs-Female |
5.357600E-01 |
| Male-vs-Female |
9.858800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.306600E-01 |
| Normal-vs-Extreme_Weight |
2.94119999999509E-06 |
| Normal-vs-Obese |
4.874200E-02 |
| Normal-vs-Extreme_Obese |
5.978400E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.812500E-02 |
| Normal_Weight-vs-Obese |
7.057400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.580800E-01 |
| Extreme_Weight-vs-Obese |
2.402100E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.647200E-01 |
| Obese-vs-Extreme_Obese |
3.272400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.156350E-02 |
| Normal-vs-Age(41-60Yrs) |
5.425600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.182140E-03 |
| Normal-vs-Age(81-100Yrs) |
5.015600E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.318000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.841200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.656000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.885450E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.270000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.849200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.976100E-04 |
| Normal-VS-Type2 PRCC |
5.90619999999431E-05 |
| Normal-VS-KIRP CIMP |
1.069870E-02 |
| Normal-VS-Unclassified PRCC |
1.018210E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.456440E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.121000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.490200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.778800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.181400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.445200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.48269999999895E-05 |
| Normal-vs-N1 |
2.577400E-01 |
| Normal-vs-N2 |
8.07080000000404E-05 |
| N0-vs-N1 |
8.727700E-02 |
| N0-vs-N2 |
2.284800E-01 |
| N1-vs-N2 |
7.354200E-02 |
|
|
